Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Skinner

Showing results (521-530 of 554) with videos related to

Pageof 56
Sort By:
NPJ Precision Oncology|October 5, 2019
Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Mona Kamal, et al.
Plos One|June 24, 2016
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic CancerAwalpreet S Chadha, Heath D Skinner, Jillian R Gunther, et al.
Cancer|January 9, 2019
Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomesTimothy A Lin, Adam S Garden, Hesham Elhalawani, et al.
Cancer Research|December 30, 2021
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling CascadeDavid P Molkentine, Jessica M Molkentine, Kathleen A Bridges, et al.
Head & Neck|April 25, 2020
Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experienceHarish Dharmarajan, Jennifer L Anderson, Seungwon Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal CancerFan Li, Yan Xu, Bovey Liu, et al.
Nature Communications|November 4, 2021
Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of functionManish Kumar, David Molkentine, Jessica Molkentine, et al.
Molecular Cell|May 27, 2014
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activationGe Zhou, Jiping Wang, Mei Zhao, et al.
Oncology|March 14, 2015
Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical ImplicationsNastaran Neishaboori, Roopma Wadhwa, Graciela M Nogueras-González, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal CancerKazuki Sudo, Xuemei Wang, Lianchun Xiao, et al.
Pageof 56

Showing results (521-530 of 554) with videos related to

Sort By:
Pageof 56
NPJ Precision Oncology|October 5, 2019
Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Mona Kamal, et al.
Plos One|June 24, 2016
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic CancerAwalpreet S Chadha, Heath D Skinner, Jillian R Gunther, et al.
Cancer|January 9, 2019
Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomesTimothy A Lin, Adam S Garden, Hesham Elhalawani, et al.
Cancer Research|December 30, 2021
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling CascadeDavid P Molkentine, Jessica M Molkentine, Kathleen A Bridges, et al.
Head & Neck|April 25, 2020
Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experienceHarish Dharmarajan, Jennifer L Anderson, Seungwon Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal CancerFan Li, Yan Xu, Bovey Liu, et al.
Nature Communications|November 4, 2021
Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of functionManish Kumar, David Molkentine, Jessica Molkentine, et al.
Molecular Cell|May 27, 2014
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activationGe Zhou, Jiping Wang, Mei Zhao, et al.
Oncology|March 14, 2015
Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical ImplicationsNastaran Neishaboori, Roopma Wadhwa, Graciela M Nogueras-González, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal CancerKazuki Sudo, Xuemei Wang, Lianchun Xiao, et al.
Pageof 56